StockNews.com began coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a report issued on Monday morning. The brokerage issued a sell rating on the biotechnology company’s stock.
22nd Century Group Stock Performance
Shares of XXII opened at $0.10 on Monday. The stock has a market capitalization of $4.80 million, a price-to-earnings ratio of 0.00 and a beta of 1.45. 22nd Century Group has a 12 month low of $0.08 and a 12 month high of $5.28. The firm has a fifty day simple moving average of $0.14 and a 200 day simple moving average of $0.53. The company has a current ratio of 1.09, a quick ratio of 0.93 and a debt-to-equity ratio of 1.59.
22nd Century Group (NASDAQ:XXII – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share for the quarter. The company had revenue of $5.95 million for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%.
Institutional Trading of 22nd Century Group
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Featured Articles
- Five stocks we like better than 22nd Century Group
- Market Cap Calculator: How to Calculate Market Cap
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Invest in Biotech Stocks
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.